Oral Presentation Australasian Society for Dermatological Research Annual Scientific Meeting 2017

Activation of the AMP-activated protein kinase (AMPK) inhibits therapy induced epigenetic remodelling and acquired drug resistance in melanoma (#24)

Heinz Hammerlindl 1 , Dinoop Ravindran Menon 1 , Abdullah Al Emran 1 , Joachim Torrano 1 , Sabrina Hammerlindl 1 , Rick Sturm 1 , Nikolas Haass 1 , Giulia Rancati 2 , Brian Gabrielli 3 , Helmut Schaider 1
  1. Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia
  2. Institute of Medical Biology, Agency for Science, Technology and Research, Singapore
  3. Mater Research Institute, The University of Queensland, Brisbane, QUEENSLAND, Australia
Publish consent withheld
  • Are you currently a student: Yes